Acetic Acid

Acetic Acid

SCHEMBL2052289

CC(=O)[O-].CC(=O)[O-].O.O.O.O.O.O.O.O.[Mn+2]

nearest known ligand 0.80

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.80
CA4 P22748 3/20 0.54
LMNA P02545 2/20 0.46
TSHR P16473 2/20 0.42
FFAR3 O14843 2/20 0.42
THPO P40225 1/20 0.42
LCK P06239 1/20 0.42
FYN P06241 1/20 0.42
ALOX15 P16050 1/20 0.39
BLM P54132 1/20 0.39
PMP22 Q01453 1/20 0.39
FAHD1 Q6P587 1/20 0.39
CES1 P23141 1/20 0.35
ALDH1A1 P00352 2/20 0.33
HDAC3 O15379 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL2345927 1.00 CA1 (0.80) CA1CA4LMNATSHRFFAR3
Acetic Acid SCHEMBL563051 1.00 CA1 (0.80) CA1CA4LMNATSHRFFAR3
Acetic Acid SCHEMBL19946523 1.00 CA1 (0.80) CA1CA4LMNATSHRFFAR3
Acetic Acid SCHEMBL5484349 1.00 CA1 (0.80) CA1CA4LMNATSHRFFAR3
Acetic Acid SCHEMBL41209 1.00 CA1 (0.80) CA1CA4LMNATSHRFFAR3
Acetic Acid SCHEMBL28408878 0.95 CA1 (0.73) CA1CA4LMNATSHRFFAR3
Acetic Acid SCHEMBL16654487 0.95 CA1 (0.73) CA1CA4LMNATSHRFFAR3
Acetic Acid SCHEMBL5278984 0.95 CA1 (0.73) CA1CA4LMNATSHRFFAR3
Acetic Acid SCHEMBL28283158 0.95 CA1 (0.73) CA1CA4LMNATSHRFFAR3
Acetic Acid SCHEMBL19836 0.95

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110970234-A Preparation method of vinylon fabric-based graphene/manganese dioxide electrode material 南通纺织丝绸产业技术研究院 2020-04-07 CN claimed
US-4097492-A OXIDATION OF PERIACENAPHTHINDENONES, CATALYSIS HOECHST AKTIENGESELLSCHAFT (DT) 1978-06-27 US claimed
CN-116234412-B High-electro-strain bismuth sodium titanate-based lead-free piezoelectric film and preparation method thereof 同济大学 2025-10-14 CN disclosed
CN-110970234-A Preparation method of vinylon fabric-based graphene/manganese dioxide electrode material 南通纺织丝绸产业技术研究院 2020-04-07 CN disclosed
EP-3519461-A1 METHOD FOR PREPARING A POLYMER Coatex (FR) 2019-08-07 EP disclosed
EP-2070966-B1 POLYESTER RESIN COMPOSITION, PROCESS FOR PRODUCTION THEREOF, AND LAMINATED POLYESTER FILM TORAY INDUSTRIES (JP) 2016-04-13 EP disclosed
EP-1206551-B2 ENZYMATIC SYNTHESIS OF DEOXYRIBONUCLEOSIDES PASTEUR INSTITUT (FR) 2011-10-26 EP disclosed
US-20110160484-A1 Method of Inhibiting Polymerization and Fouling in Acrylic Acid and Acrylate Processes ARKEMA INC. 2011-06-30 US disclosed
EP-2070966-A1 POLYESTER RESIN COMPOSITION, PROCESS FOR PRODUCTION THEREOF, AND LAMINATED POLYESTER FILM Toray Industries, Inc. (JP) 2009-06-17 EP disclosed
EP-1206551-B1 ENZYMATIC SYNTHESIS OF DEOXYRIBONUCLEOSIDES PASTEUR INSTITUT (FR) 2009-05-13 EP disclosed
EP-1146068-B1 Trimethylene-2,6-naphthalenedicarboxylate Copolymer Film, Quaternary Phosphonium Sulphonate Copolymer and Compositions thereof TEIJIN LTD (JP) 2008-12-24 EP disclosed
US-7122616-B2 Polyester composition and process for producing the same TEIJIN FIBERS LIMITED (JP) 2006-10-17 US disclosed
US-20050085595-A1 Polyester composition and process for producing the same TEIJIN FIBERS LIMITED 2005-04-21 US disclosed
US-5644019-A High activity catalytic system for the synthesis of poly(ethylene terephthalate) ENICHEM S.P.A. (IT) 1997-07-01 US disclosed
US-5639889-A USING IODOSOBENZENE AS AN OXIDIZING AGENT AND AN OPTICALLY ACTIVE MANGANESE COMPLEX AS CATALYST TO PRODUCE AN OPTICALLY ACTIVE BENZOPYRAN COMPOUND NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 1997-06-17 US disclosed
EP-0745630-A2 High activity catalytic system for the synthesis of poly(ethylene terephthalate) ENICHEM S.p.A. (IT) 1996-12-04 EP disclosed
EP-0618247-A2 Polyesters of 2,6-naphthalenedicarboxylic acid with a reduced crystallization rate ENIRICERCHE S.p.A. (IT) 1994-10-05 EP disclosed
US-5352814-A Optically active manganese complex NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 1994-10-04 US disclosed
EP-0535377-A2 Optically active benzopyran compound, process for producing it and optically active manganese complex NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1993-04-07 EP disclosed
US-4097492-A OXIDATION OF PERIACENAPHTHINDENONES, CATALYSIS HOECHST AKTIENGESELLSCHAFT (DT) 1978-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110160484-A1 Method of Inhibiting Polymerization and Fouling in Acrylic Acid and Acrylate Processes HAO2, AOC2, HACL2 CA1 62/4885CA4 78/4885LMNA 1103/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.